Web Business Outline Presentation February 1, 2012

Millennium Vascular & Cardio Care

Practice Management & Development Services

Coding Medical Devices ProComm Billing

OTC Pink: MHCC

MEDICAL PRACTICE MANAGEMENT SERVICES

Additional Services Provided:

Safe Harbor Statement Under the Private Securities Litigation Act of 1995

With the exception of historical information, the matters discussed herein are forward-looking statements that involve a number of risks and uncertainties. The actual future results of Millennium Healthcare, Inc.(the “Company”) could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rate and unanticipated events such as terrorist activities.

In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved, particularly if we have provided projected revenues or forecasts, which are all simply estimates based on the opinions of management. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors see the risk factors associated with our Company, please review our SEC filings

2

Millennium HealthCare strives to provide innovative and effective practice management services to assist Cardiology & Vascular specialists in growing their practice. Our services enable the physician to offer their patients top quality and convenient facility patient care with greater comfort and ease for both doctor and patient.

3

Primary Services Provided:

Vascular Management Services

• Medical practice management & development service for physician’s primarily focusing on vascular disorders such as peripheral arterial disease (PAD) . These minimally invasive procedures for (PAD) are performed by a highly skilled team of Interventional Cardiologist’s and Vascular Surgeon’s who specialize in this care and treatment. Millennium Vascular Management Group offers these physicians an alternative office based setting to enhance patient care & comfort, physician flexibility and clinical outcome.

Cardiology Management Services

• The cardiology practice management & development service offers practitioners a flexible business alternative to expand their patient retention and flow by providing advanced cardiology care & testing capabilities within their existing office setting . Advanced In-house services promotes long-term patient retention and revenue for their practice.

Additional Services Offered:

Billing Coding Medical Devices ProComm

4

Company Overview

Alternative-reporting OTC Pink : MHCC

Common Shares Outstanding a/o 11/30/11: 16,919,122

Current Market Capitalization @$1.25: $21,150,000

Additional information may be found at:

www.millenniumhcs.com & www.proactivenewsroom.com/mhcc

Disease and Stroke Statistics-2011 Update:

Most Costly Diseases Cardio Vascular Diseases and stroke accounted for 15% of the total health expenditures in 2007. The total

cost and the indirect mortality cost estimates for CVD are higher than for any other major diagnostic group. By way of comparison, CVD total direct and indirect costs are higher than the official National Cancer Institute estimates for cancer and benign neoplasms in 2010, which were cited as $264 billion total, $103 billion direct, $21 billion indirect morbidity, and $140 billion indirect cost of mortality.

Peripheral Arterial Disease ● Peripheral arterial disease (PAD) affects 8 million Americans and is associated with significant morbidity and

mortality. Prevalence increases dramatically with age, and PAD disproportionately affects blacks.

● PAD affects 12% to 20% of Americans 65 years of age. Despite its prevalence and cardiovascular risk implications,

only 70% to 80% of patients with PAD undergo recommended antiplatelet therapy or lipid-lowering therapy.

● In the general population, only 10% of people with PAD have the classic symptom of intermittent claudication.

Approximately 40% do not complain of leg pain, whereas the remaining 50% have a variety of leg symptoms different

from classic claudication. In an older, disabled population of women, however, as many as two thirds of individuals

with PAD had no exertional leg symptoms.ation and Costs

• on trends and current usage of cardiovascular surgical and invasive procedures shows the total number of inpatient

5 5

Industry Facts & Trends

Disease and Stroke Statistics-2011 Update:

Cardiovascular Procedure Utilization and Costs

Data on trends and current usage of cardiovascular surgical and invasive procedures shows the total number of inpatient cardiovascular operations and procedures increased 27%, from 5,382 000 in 1997 to 6,846 000 in 2007 (National Heart, Lung, and Blood Institute computation based on National Center for Health Statistics annual data). Reviews of current estimates of direct and indirect healthcare costs related to Cardio Vascular Diseases (CVD), stroke, and related conditions using Medical Expenditure Panel Survey data. The total direct and indirect cost of CVD and stroke in the United States for 2007 is estimated to be $286 billion.

More information can be found at the National Center for Health Statistics Web site,http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_01.pdf.

The online version of this article, along with updated information and services,

Is located on the World Wide Web at :http://circ.ahajournals.org/content/123/4/e18

6

Industry Facts & Trends

Vision

Our vision is to create a physician friendly business structure and combine it with experienced dedicated health care professionals relentlessly committed to their patients. Our Practice Management Group supports & manages cardio physician practices with an emphasis on the diagnosis and treatment of Peripheral Arterial Disease (PAD) of the lower extremities. We partner with top rated physicians skilled in the practice of Interventional Cardiology.

Vascular Surgery and Radiology.

7

Millennium Vascular & Cardio Care Management Group

“About 10 million American adults have peripheral artery disease (PAD).

Although it was once believed that PAD occurs more often in men than women, current research now indicates that both genders are equally susceptible.

African-Americans have twice the risk for PAD as Caucasians. Between 15 - 20% of people over age 65 suffer from the condition.”

Millennium Vascular Management

Geographical Targets for 2012:

-Staten Island, New York

-Central New Jersey

-Southern New Jersey

-Florida

-Philadelphia, PA

-Atlanta

-Queens, New York

-Westchester, New York

Procedural Focus:

- Lower Extremity Arterial Diagnosis

- Catheter Placement

- Catheter Removal

- Venous PTA / Stent

- Arterial PTA

- Arterial Stent Placement

- Atherectomy

8

Business Development Strategy

• Experienced Management Team with significant outpatient cardiology & vascular expertise.

• Identification of initial national footprint and access to highly skilled Interventionalists

• Current Marketplace ripe for expansion

• High Margin/Significant Cash-Flow Opportunity

• Current Insurance reimbursement favorable versus Hospital alternative

• Beneficial for Patient & Physician

9

Scheduled Opening - February- 2012

Millennium Vascular Management Group

of Staten Island

Millennium Cardio Care

Market Segment Strategic Advantages:

- Insurance Carriers pay for pre-cursor testing & minimally invasive medical procedures to avoid long hospital stays and open procedures.

- target physicians in highly populated urban areas.

- Cardiology patient flow is a natural referral source for skilled Vascular Team.

- Cardio model offers many medical groups a flexible model to keep patients in house with advanced cardio testing & physicians access.

Geographical Targets for 2012

-New York

-Florida

-New Jersey

-

10

Millennium Cardiology Management patient mix

represents a natural Internal Medicine / Referral

source for our entire network of Healthcare

Divisions. Cardio Management & Development

represents our first introduction to a cardio patient

that many be requiring more advanced care. Our

Vascular Group’s will be geographically located near

many Cardio locations to deliver patient comfort and

access to top-level Vascular physician’s.

Cardiology Service -Initial patient evaluation & consultation -EKG -Echocardiogram -Stress Echocardiogram -Abdominal Aorta -Renal Doppler -Arterial Duplex -Venous Duplex -PVR -Holter Monitoring -ABI -Exercise PVR -Pulmonary Stress Test -Nuclear Stress testing -Cardiac PET

Additional Services Offered:

Coding Services

• Secure Remote or On-Site Coding

• ICD-10 Code Management

• Concurrent and Retrospective CDI Reviews

• DRG Validation Services

• DRG Reassignment Appeals

11

Billing Services

• Billing and Collections

• Electronic Medical Records

• Equipment Management

• Financing Services

• Lock-box management

ProComm Services •Reliable Live Answering 24/7 Full Service Call Processing •State of the Art Operating System with Call overflow Management •Emergency Message / Dispatch •Confidential Call Recording •Receptionist Services and/or Voice Mail Messages & Screening •Archive Message Services •HIPAA Compliance / Training •Never Down Environment (24 Hours a Day, 365 Days a Year)

Medical Devices

Test Kits :

• Cardiology Examinations

• Vascular Examinations

• Doctor’s Test Kit

MANAGEMENT TEAM

• Dominick Sartorio – CEO & Chairman of Millennium HealthCare Inc. served as Director of New Business for a Wall Street management consulting firm, utilizing his expansive understanding of business strategy to spearhead the company’s continued growth. As Director of New Business, he quickly employed his capabilities to the utmost degree, creating and implementing initiatives for client companies’ worth up to $550 million in annual sales. Mr. Sartorio was placed as acting CEO of a global technology firm, directing the research and development process, patent approval, product launch, and the negotiation of a 2-year, $800 million sales agreement. Prior, Mr. Sartorio co-founded a highly successful manufacturing and distribution company maintaining global reach in numerous industries such as medical, chemical and emerging technology markets. During his tenure, Mr. Sartorio accomplished a great deal, vastly improving the profitability and cash flow of numerous holding companies and implementing efficiencies, policies and procedures that had a global impact . Among Mr. Sartorio’s many achievements, the development of the world’s largest synthetic vitamin B4 and antioxidant manufacturing facility is particularly of note. Under his supervision and leadership, this facility produced in excess of 100 million pounds of product per year while remaining in compliance with standards set forth by the Food and Drug Administration (FDA), the Environmental Protection Agency (EPA), the Occupational Safety and Health Administration (OSHA) and the Drug Enforcement Agency (DEA).

• Chris Amandola – President & Director has more than 15 years of Professional Management, Senior Management and Entrepreneurial experience in the Medical device arena. Chris has held positions at such high profiled Medical device Companies like C.R. Bard Inc., Boston Scientific Corp. and Smith & Nephew Inc. Chris has experience and extensive knowledge in fields of Peripheral Vascular, Coronary, Gastroenterology, Wound Care and Infection Control. Chris has worked closely and forged relationships with key opinion leaders around the U.S. in each of these specialties. Mr. Amandola has provided strong executive leadership including the management and direction of forecasting activities, budgeting, and successful market launch of new and innovative products in the medical field. Chris has also negotiated and implemented key account contracts at many Major Health Systems across the U.S. He has been responsible for managing the ongoing revenue and growth at all of these companies. Mr. Amandola has excelled in organizing, training and executing sales distribution strategies for various medical products all within the healthcare industry.

12

MANAGEMENT TEAM

• Anthony Urbano - Chief Financial Officer, Secretary & Director has over 18 years of forensic and financial accounting, finance, administration, operational, sales/marketing budgets and projections, advisory and managerial experience in entrepreneurial and high-growth companies. His experience comes from a variety of industries including, manufacturing, distribution, small cap / start-ups, financial markets and financial data reporting, automotive, technology and media / entertainment. Mr. Urbano has provided strong executive leadership for companies including the management and direction of cash/profitability forecasting activities, budgeting, implementation of financial reporting structures, financial analyses, evaluation and recommendations of company information systems, sales and marketing initiatives, audit support, infrastructures, traditional and alternative financing, information technology, cost and debt reduction initiatives, restructuring and strategic planning.

Mr. Urbano also has extensive experience in managing reporting, compliance and issue resolutions for government regulatory bodies including departments of corporations, departments of labor, departments of taxation and most phases of SEC reporting (pre-SOX), including 10-Q, 10-K, 8-K, delisting, relisting, commentary periods (textual and accounting), NASDAQ OTC and BB status and inquiries/investigations. He also has executed the planning, design and implementation of complete human resource / employee benefit and retirement initiatives, information technology infrastructures and corporate/commercial risk management.

• Richard DeMaio – Chief Information Officer is currently the President of Heartbeat Medical PC, an AMSURG-Cardiology Center and Management Services Organization that provides a full suite of consulting services to private practices, AMSURG facilities and hospitals. Heartbeat is a related subsidiary of Premier HealthCare Resources, one of the largest providers of cardiovascular services in the New York area with over 30 locations under management. Mr. DeMaio has over 15 years of superior experience in the healthcare industry, commanding senior level executive positions with Long Island Jewish Medical Center, Brookdale Hospital Medical Center and Sonix Medical Resources. His experience comes from a variety of administration and operations management including renovation and expansion of facilities, development and implementation of centers, Federal and State Departments of Health and Public Council Compliance, development, implementation and seamless integration of new products/services and overall effective and efficient medical and physician practice development and management.

13

ADVISORY BOARD MEMBERS

• Marc Sherman, MD FACC currently serves as the Medical Director of Heartbeat Medical PC and is also an active member with Medical Health Associates of Bellerose, DOC Care, Midtown Internal Medicine, R and L Medical Associates and Total Medical PC. Dr. Sherman also currently serves as attending staff/medical staff physician at NYU Hospital, St. Luke’s/Roosevelt Hospital and St John’s Medical Center. Dr. Sherman is Board Certified from the American Board of Internal Medicine for Internal Medicine and Cardiovascular Disease, and holds an active license to practice medicine in the State of New York.

• Elias Zias, MD currently serves as attending physician at St. John’s Medical Center, St. Joseph’s Medical Center, Community Hospital at Dobbs Ferry, Hudson Valley Hospital Center and NY School of Medicine NYU Langone Medical Center. Dr. Zias also holds an academic appointment as Clinical Associate Professor at the NYU School of Medicine, holds fellowships with the American College of Cardiology and the American College of Surgeons and has been published numerous times. Dr. Zias is Board Certified from the American Board of Surgery and the American Board of Thoracic Surgery, and holds an active license to practice medicine in the States of New York, Connecticut and Illinois.

• Edward Joyce – Vice President of Sales and Marketing - has over 17 years experience in medical sales and medical sales management. Edward has spent time with and has a long history of success with leading medical device manufacturers such as C.R. Bard Inc., Edwards Life sciences and St. Jude Medical. His expertise includes but is not limited to managing as well as building professional sales organizations. Throughout Edward’s tenure he has called on numerous areas of hospitals including Infection Control, Housekeeping, Cardiology, Radiology, ICU’s as well as the Operating Room. In each of these departments Edward has built tremendous relationships across the United States and brings with him a large network of KOL’s in each of these areas. Edward has also successfully managed to launch a variety of new technology in each of the aforementioned hospital departments in which he had a key role in both sales related and marketing related strategies.

• Mark Allen – Southeast Regional Director of Sales- Mr. Allen has close to 20 years of Medical device sales, sales management and medical recruiting. Mark has held positions at some of the premiere medical device companies in the industry, Stryker, Inamed, Abbot Vascular, to name a few. Mr. Allen’s comes to Millennium after being the Director of Business Development for Vascular Access Centers (VAC). Mark developed relationships with the top physicians domestically in the fields of Interventional Cardiology, Interventional Radiology and Vascular Surgery. He was instrumental in their recruitment, contractual obligation, ownership and driving revenue. In the last 12 months he's been responsible for recruiting and signing 15 physicians to 6 new centers. This included and not limited to the negotiating of real estate, employees, marketing, equipment, and all start up costs involved. Mark has successfully negotiated contract with all the medical device manufactures and distributors associated with these centers.

14

15 15

Heart Disease & Stoke Statistics - 2011